Ping An Biomedical plans to buy three tumor-related patents for $2 million-$2.5 million
PASW•Ping An Biomedical signed a letter of intent to acquire three tumor-related medical technology patents from Future Biotechnology Group for $2 million to $2.5 million. The company said the acquisition alone is not expected to generate material near-term revenue.
1. Planned patent acquisition
Ping An Biomedical signed a letter of intent to acquire three tumor-related medical technology patents from Future Biotechnology Group for $2 million to $2.5 million. The planned acquisition would establish an oncology and biotechnology intellectual property portfolio to support longer-term healthcare development, but no material near-term revenue is expected from the acquisition alone.
